Germany limits general use of AstraZeneca jabs to people under 60 | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Thursday
June 08, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
THURSDAY, JUNE 08, 2023
Germany limits general use of AstraZeneca jabs to people under 60

Coronavirus chronicle

Reuters
31 March, 2021, 08:30 am
Last modified: 31 March, 2021, 08:58 am

Related News

  • Germany is running out of workers, putting growth in jeopardy
  • Europe's economic engine is breaking down
  • German startup attempting to reverse death and resurrect humans
  • Russia summons Germany, Denmark, Sweden envoys over 'stalled' Nord Stream investigation
  • German court jails five over spectacular heist at Dresden museum

Germany limits general use of AstraZeneca jabs to people under 60

Germany’s federal and state health ministries agreed that under 60-year-olds should only receive the AstraZeneca vaccine if they belong to high-priority groups, which include high-risk patients and medical workers, in consultation with a doctor

Reuters
31 March, 2021, 08:30 am
Last modified: 31 March, 2021, 08:58 am
A vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. REUTERS/Hannibal Hanschke
A vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. REUTERS/Hannibal Hanschke

Germany will from Wednesday limit the use of AstraZeneca's Covid-19 vaccine to people aged 60 and above as well as high-priority groups following further reports of a rare brain blood disorder.

"We have to be able trust the vaccines," Chancellor Angela Merkel told journalists at a news conference on Tuesday. "And transparency is the best way to deal with such a situation," she added.

Acting on advice from Germany's vaccine committee, known as STIKO, Germany's federal and state health ministries agreed that under 60-year-olds should only receive the AstraZeneca vaccine if they belong to high-priority groups, which include high-risk patients and medical workers, in consultation with a doctor.

People aged below 60 who have already received a first AstraZeneca shot have the option of either receiving their second shot as planned, if they are high priority, or to wait for STIKO to issue its recommendation, which it is expected to do by the end of April.

The new limit on the use of AstraZeneca's vaccine is another setback in Germany's already sluggish vaccination campaign.

Earlier, STIKO recommended the shot only be used for people aged 60 and above "on the basis of available data on the occurrence of rare but very severe thromboembolic side-effects".

STIKO is also looking into the possibility of administering a second shot with a different COVID vaccine.

In a statement responding to the STIKO recommendation, AstraZeneca said patient safety was its highest priority and noted the European and UK medical agencies had not been able to establish a causal relationship between the shot and clotting.

"We will continue to work with German authorities to address any questions they may have," it added.

Germany will, however, allow anyone 60 and over to be given the AstraZeneca shot in an effort to speed its vaccination campaign. So far, it has only been vaccinating people aged over 70 and those in high priority groups.

Back And Forth

Germany's decision followed further reports by the country's vaccine regulator, the Paul Ehrlich Institute, of cases of blood clots known as cerebral sinus vein thrombosis.

PEI said it had registered 31 cases of CSVT, which resulted in nine deaths, out of some 2.7 million people who have received the AstraZeneca vaccine. With the exception of two cases, all reports involved women aged between 20 and 63.

Because use of the vaccine in Germany was initially limited to those under 65, the shot has been administered among younger women, particularly medical staff and teachers.

Many European countries briefly stopped using AstraZeneca's vaccine earlier this month while investigating rare cases of blood clots.

Both the European Medicines Agency (EMA) and the World Health Organization said this month the benefits of AstraZeneca's vaccine outweighed the risks.

An EMA review covering 20 million people who took the AstraZeneca shot in Britain and the European Economic Area found seven cases of blood clots in multiple blood vessels and 18 cases of CVST.

Millions of doses of the AstraZeneca vaccine have been safely administered around the world.

Nearly all countries have since resumed use of the vaccine. But France broke with guidance from the EMA and said on March 19 it should only be given to people aged 55 or older. France said the decision was based on evidence that the clotting affected younger people.

Canadian health officials said on Monday they would stop offering AstraZeneca's shot to people under 55 and require a new analysis of the shot's benefits and risks based on age and gender.

Bavarian Premier Markus Soeder criticised the "back and forth" around the vaccine, saying all recommendations showed that the danger of severe illness from the coronavirus outweighed any side-effects linked to the shot.

Top News

german / Germany / Coronavirus Pandemic / covid-19 vaccine / AstraZeneca Covid-19 Vaccine / AstraZeneca vaccine / STIKO

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Weak taka number one risk for macro stability: Finance
    Weak taka number one risk for macro stability: Finance
  • Load-shedding rewrites record every day
    Load-shedding rewrites record every day
  • Representational image. Photo: MumitM/TBS
    Power Supply from Adani disrupted over transmission line fault

MOST VIEWED

  • Covid is no longer global health emergency: WHO
    Covid is no longer global health emergency: WHO
  • Federal police officers stand guard near the house of former Brazilian President Jair Bolsonaro, during a search operation at his home, in Brasilia, Brazil, 3 May, 2023. REUTERS/Adriano Machado
    Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • World Health Organization logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS/Dado Ruvic/Illustration//File Photo
    Covid here to stay but moving out of emergency phase: WHO
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India reports 12,591 new Covid cases today, 20% more than yesterday
  • People queue up outside a quick test centre to take their coronavirus disease (Covid-19) antigen rapid tests, in Singapore September 21, 2021. Photo :Reuters
    Singapore witnesses new Covid wave: ‘Cases are mostly mild’
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India logs 5,676 new Covid cases, active infections cross 37,000-mark

Related News

  • Germany is running out of workers, putting growth in jeopardy
  • Europe's economic engine is breaking down
  • German startup attempting to reverse death and resurrect humans
  • Russia summons Germany, Denmark, Sweden envoys over 'stalled' Nord Stream investigation
  • German court jails five over spectacular heist at Dresden museum

Features

Illustration: TBS

Why aspiration mismatch is a bigger challenge than skill mismatch

12h | Pursuit
Akhand Bharat: What's in a map?

Akhand Bharat: What's in a map?

16h | Panorama
Treatment is a byproduct, not the focus: Inside Bangladesh's largest specialised burn institute 

Treatment is a byproduct, not the focus: Inside Bangladesh's largest specialised burn institute 

13h | Panorama
Marcus Ashworth/Columnist

Brics raging against the dollar is an exercise in futility

13h | Panorama

More Videos from TBS

DU students are suffering due to electricity

DU students are suffering due to electricity

11h | TBS Stories
'Lal Biroi' in Gaibandha

'Lal Biroi' in Gaibandha

12h | TBS Stories
Imran fears re-arrest

Imran fears re-arrest

1d | TBS World
Zlatan Ibrahimovic retires from football

Zlatan Ibrahimovic retires from football

1d | TBS SPORTS

Most Read

1
bKash denied permission to pay $4.10 lakh for Argentina football partnership
Banking

bKash denied permission to pay $4.10 lakh for Argentina football partnership

2
Photo: Noor-A-Alam/TBS
Splash

The Night Dhaka did NOT vibe with Anuv Jain

3
Country's first floating solar power plant connected to national grid
Energy

Country's first floating solar power plant connected to national grid

4
Photo: TBS
Environment

Green space in Dhaka North declines 66% in 3 decades: Study

5
Photo: TBS
Energy

2nd unit of Payra power plant to shut down over coal shortage

6
Photo: Md Jahidul Islam
Environment

After Dhaka South, Dhaka North fells trees on Technical intersection

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]